• Onconetix entered a $30.25 million PIPE on July 28, 2026 through an unregistered sale of 37,812 shares of Series F convertible preferred stock.
• Series F carries a $1,000 stated value per share, convertible into common stock at an initial conversion price of $0.98.
• Registration rights granted for common shares issuable on conversion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Onconetix Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-082879), on July 29, 2026, and is solely responsible for the information contained therein.